Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04085614 · ClinicalTrials.gov registry record · NA

Dynamic Coronary Roadmap for Contrast Reduction

A NA study, sponsored by Philips Clinical & Medical Affairs Global.

Completed
Registry status
NA
Development phase
371
Enrollment target

NCT04085614 is a NA study that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 371 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04085614, a NA study, has completed, sponsored by Philips Clinical & Medical Affairs Global.

COMPLETED
Registry status
NA
Development phase
371 participants
Enrollment target

Study Summary

The Dynamic Coronary Roadmap is a commercially available product developed by Philips Medical Systems, a Philips Healthcare company. Dynamic Coronary Roadmap is a software medical device intended to provide a real-time and dynamic angiographic roadmap of coronary arteries. The angiographic roadmap is automatically generated from previously acquired coronary angiograms during the same procedure. Dynamic Coronary Roadmap overlays the angiographic roadmap on live 2D fluoroscopic images, thereby assisting the physician in navigating devices, e.g. (guide) wires, catheters, through the coronary arteries. This is a multi-center, prospective, unblinded, stratified 1:1 randomized controlled trial to assess whether using Dynamic Coronary Roadmap reduces the total iodinated contrast volume related to Percutaneous Coronary Intervention (PCI) compared to the control group without Dynamic Coronary Roadmap.

Interventions

  • DEVICE Percutaneous Coronary Intervention (PCI) with Dynamic Coronary Roadmap
  • DEVICE Percutaneous Coronary Intervention (PCI) without Dynamic Coronary Roadmap

Trial Details

FieldValue
Enrollment Target 371 participants
Start Date 2019-10-01
Est. Completion 2023-02-09
Phase NA

What the Registry Record Tells You About NCT04085614

The ClinicalTrials.gov registry entry for NCT04085614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 371 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Percutaneous Coronary Intervention (PCI) with Dynamic Coronary Roadmap is the first listed.

NCT04085614 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04085614 about?

NCT04085614 is a clinical study titled "Dynamic Coronary Roadmap for Contrast Reduction". The Dynamic Coronary Roadmap is a commercially available product developed by Philips Medical Systems, a Philips Healthcare company. Dynamic Coronary Roadmap is a software medical device intended to provide a real-time and dynamic angiographic roadmap of coronary arteries. The angiographic roadmap i...

What is the current status of trial NCT04085614?

This trial is currently completed. It is a NA study. The enrollment target is 371 participants. The study started on 2019-10-01. Estimated completion is 2023-02-09.

What interventions are being tested in trial NCT04085614?

The interventions under investigation include: Percutaneous Coronary Intervention (PCI) with Dynamic Coronary Roadmap (DEVICE), Percutaneous Coronary Intervention (PCI) without Dynamic Coronary Roadmap (DEVICE).

Who is sponsoring clinical trial NCT04085614?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.